|
|
Product List Page 1660
|
|
Product ID |
Product Name |
CAS# |
Purity |
Y3304534 |
Boronic acid, B-[5-(1,1-dimethylethyl)-2-ethoxyphenyl]- |
1217501-13-7 |
95% |
Y1289571 |
Boronic acid, B-(2-bromo-4-fluorophenyl)- |
1217501-12-6 |
98% |
Y1243742 |
Boronic acid, B-[4-[1-(hydroxymethyl)cyclopropyl]phenyl]- |
1217501-10-4 |
98% |
Y1340856 |
Boronic acid, B-[4-[(2-methylpropyl)sulfonyl]phenyl]- |
1217500-99-6 |
97% |
Y3236857 |
Boronic acid, B-[4-[(2-methylpropyl)thio]phenyl]- |
1217500-97-4 |
95% |
Y1340952 |
Boronic acid, B-[4-[(3-methylbutyl)sulfonyl]phenyl]- |
1217500-93-0 |
95% |
Y3212383 |
Boronic acid, B-[4-fluoro-3-[(tetrahydro-2H-pyran-2-yl)oxy]phenyl]- |
1217501-17-1 |
95% |
Y3314489 |
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, 1-(1-methylethyl) 9-propyl ester, 5-oxide |
1217542-13-6 |
95% |
Y1334892 |
Boronic acid, B-[4-[(cyclopropylamino)sulfonyl]-2-methylphenyl]- |
1217501-49-9 |
98% |
Y1340857 |
Boronic acid, B-[4-[(ethylamino)sulfonyl]-2-methylphenyl]- |
1217501-46-6 |
95% |
Y1252863 |
Boronic acid, B-(2-butoxy-5-chloro-3-pyridinyl)- |
1217501-44-4 |
98% |
Y1252933 |
Boronic acid, B-[5-chloro-2-(1-methylethoxy)-3-pyridinyl]- |
1217501-41-1 |
96% |
Y1252962 |
D-Phenylalanine, 2-(aminomethyl)- |
1217601-79-0 |
99% (TLC) |
Y1334829 |
D-Phenylalanine, 2,4,5-trifluoro- |
1217601-63-2 |
97% |
Y1041017 |
Benzenesulfonamide, N,N'-[(1R,2R)-1,2-diphenyl-1,2-ethanediyl]bis[4-methyl- |
121758-19-8 |
98% |
Y1252971 |
D-Phenylalanine, 2-(aminocarbonyl)- |
1217613-52-9 |
99% (Assay by titration on dried basis) |
Y1252935 |
D-Phenylalanine, 4-(aminocarbonyl)- |
1217609-39-6 |
98% (HPLC, TLC) |
Y1054322 |
D-Proline, 2-[(2-fluorophenyl)methyl]-, hydrochloride (1:1) |
1217651-48-3 |
95% |
Y1252828 |
L-Phenylalanine, 3-(aminocarbonyl)- |
1217651-22-3 |
99% (Assay: Anhydrous Basis) |
Y1340858 |
3-Pyridinepropanoic acid, ß-amino-, ethyl ester, hydrochloride (1:2), (ßR)- |
1217631-87-2 |
97% |
Y3241635 |
D-Phenylalanine, 4-(aminomethyl)- |
1217662-97-9 |
99% (HPLC) |
D768174 |
2-Furanpropanoic acid, ß-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (ßR)- |
1217662-55-9 |
98% |
Y1041025 |
1,3-Piperazinedicarboxylic acid, 1-(1,1-dimethylethyl) 3-methyl ester, hydrochloride (1:1), (3S)- |
1217702-80-1 |
95% |
Y1041026 |
1-Piperidinecarboxylic acid, 3-(aminomethyl)-, 1,1-dimethylethyl ester, hydrochloride (1:1), (3S)- |
1217702-57-2 |
95% |
Y1252953 |
Cyclohexanemethanamine, 4-(5-methyl-2-benzoxazolyl)-, trans- |
1217702-12-9 |
95% |
D768177 |
1,2,4-Piperazinetricarboxylic acid, 4-(1,1-dimethylethyl) 1-(9H-fluoren-9-ylmethyl) ester, (2R)- |
1217723-28-8 |
95% |
D951804 |
1-Piperazinecarboxylic acid, 2-methyl-, phenylmethyl ester, hydrochloride (1:1), (2S)- |
1217720-49-4 |
97% |
Y3291459 |
Levofloxacin-d8 |
1217716-71-6 |
99% |
Y3243115 |
1-Piperidinecarboxylic acid, 3-(cyanomethyl)-, 1,1-dimethylethyl ester, (3S)- |
1217710-12-7 |
95% |
Y1252972 |
3-Piperidineacetic acid, 1-[(1,1-dimethylethoxy)carbonyl]-, methyl ester, (3S)- |
1217737-76-2 |
95% |
D951805 |
2-Furanpropanoic acid, ß-[[(1,1-dimethylethoxy)carbonyl]amino]-, (ßS)- |
1217736-81-6 |
95% |
D762057 |
3-Pyrrolidinecarboxylic acid, 5-oxo-1-(phenylmethyl)-, (3R)- |
1217736-39-4 |
95% |
Y1252925 |
Benzenepropanoic acid, ß-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxy-4-(trifluoromethyl)-, (aR,ßR)-rel- |
1217733-31-7 |
97% (HPLC) |
Y1340954 |
1-Pyrrolidineethanamine, a-(1-methylethyl)-N-2-propen-1-yl-, hydrochloride (1:2), (aS)- |
1217726-86-7 |
97% |
Y3314514 |
2-Furanpropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-, (βR)- |
1217725-33-1 |
97% |
D951806 |
1-Piperazinecarboxylic acid, 3-(phenylmethyl)-, phenylmethyl ester, hydrochloride (1:1), (3S)- |
1217779-31-1 |
95% |
Y1252954 |
D-Phenylalanine, 3-(aminocarbonyl)- |
1217747-36-8 |
100% (HPLC, ee) |
Y3246733 |
Benzenebutanoic acid, ß-amino-2,4,5-trifluoro-, hydrochloride (1:1), (ßS)- |
1217809-78-3 |
97% |
Y3311035 |
1H-Imidazole, 1-(phenylmethoxy)- |
121779-19-9 |
97% |
Y1041033 |
FMOC-(2R,3S)-2-AMINO-3-HYDROXY-4-METHYLPENTANOIC ACID |
1217833-77-6 |
95% |
Y3253853 |
1-Pyrrolidinecarboxylic acid, 3-(2-pyridinylthio)-, 1,1-dimethylethyl ester, (3R)- |
1217850-83-3 |
95% |
D768180 |
L-Histidine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-1-(triphenylmethyl)- |
1217840-61-3 |
98% |
Y1261206 |
D-Proline, 2-[[4-(trifluoromethyl)phenyl]methyl]-, hydrochloride (1:1) |
1217861-80-7 |
98% (HPLC) |
D762058 |
L-Proline, 2-[(2-methylphenyl)methyl]-, hydrochloride (1:1) |
1217859-15-8 |
95% |
K01915 |
Carbamic acid, N-[(3R)-3-pyrrolidinylmethyl]-, 1,1-dimethylethyl ester, hydrochloride (1:1) |
1217858-20-2 |
95% |
Y3224690 |
1-Piperidinecarboxylic acid, 3-(aminomethyl)-, phenylmethyl ester, (3S)- |
1217977-05-3 |
95% |
Y1265608 |
4H-1-Benzopyran-4-one, 6-bromo-2-phenyl- |
1218-80-0 |
98% |
D746002 |
Ethanone, 2-hydroxy-1,2-bis(4-methylphenyl)- |
1218-89-9 |
98.0% |
Y1261226 |
4H-1-Benzopyran-4-one, 6-fluoro-2-phenyl- |
1218-82-2 |
97% (HPLC) |
D745529 |
1-Pyrrolidinecarboxaldehyde, 2-(methoxymethyl)-, (R)- (9CI) |
121817-71-8 |
98.0% |
Y1334834 |
Cyclohexaneacetic acid, a-amino-, 1,1-dimethylethyl ester |
1218397-71-7 |
97% |
Y1338385 |
Molybdenum, dichlorobis(5-2,4-cyclopentadien-1-yl)- |
12184-22-4 |
99% |
Y1261227 |
2-Pyrimidinamine, N-cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- |
1218789-33-3 |
95% |
Y3262757 |
Benzoyl chloride, 2-chloro-4,5-difluoro- |
121872-95-5 |
95% |
D746145 |
Ethanone, 1-(2-chloro-4,5-difluorophenyl)- |
121872-94-4 |
98% |
Y1340859 |
1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-[3-methyl-5-(1-methylethoxy)phenyl]- |
1218789-75-3 |
96% |
Y1256901 |
1,3,2-Dioxaborolane, 2-[3-bromo-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]phenyl]-4,4,5,5-tetramethyl- |
1218789-51-5 |
95% |
Y1261228 |
1,3,2-Dioxaborolane, 2-[3-bromo-5-(cyclopropylmethoxy)phenyl]-4,4,5,5-tetramethyl- |
1218789-49-1 |
95% |
Y1256904 |
2-Pyrimidinamine, N-[(4-methoxyphenyl)methyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- |
1218790-01-2 |
98% |
Y1334837 |
2-Pyrimidinamine, N-(2-furanylmethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- |
1218790-00-1 |
98% |
Y1334836 |
Thiazole, 2-ethyl-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- |
1218789-94-6 |
95% |
Y1256957 |
Pyridine, 2-(diethoxymethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- |
1218790-41-0 |
97% |
Y1265683 |
1,3,2-Dioxaborolane, 2-(3-bromo-5-propoxyphenyl)-4,4,5,5-tetramethyl- |
1218790-36-3 |
97% |
D964655 |
1H-Indole-1-carboxylic acid, 6-bromo-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 1,1-dimethylethyl ester |
1218790-27-2 |
95% |
Y1340824 |
Benzoic acid, 2-chloro-5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 1,1-dimethylethyl ester |
1218790-25-0 |
96% |
Y3243398 |
Boronic acid, B-(4-butoxy-3,5-dichlorophenyl)- |
1218790-72-7 |
95% |
Y3247210 |
Boronic acid, B-(2-fluoro[1,1'-biphenyl]-3-yl)- |
1218790-57-8 |
98% |
D951810 |
Boronic acid, B-[5-(1-pyrrolidinyl)-3-pyridinyl]- |
1218790-56-7 |
97% |
Y1256922 |
[1,2,5]Oxadiazolo[3,4-b]pyridine, 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- |
1218790-54-5 |
95+% |
Y1265609 |
1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-[2-[2-(trimethylsilyl)ethynyl]phenyl]- |
1218790-52-3 |
95% |
Y3238126 |
Boronic acid, B-(3-ethyl-4-formylphenyl)- |
1218790-94-3 |
95% |
Y3245057 |
Boronic acid, B-(2,6-dichloro-3-formylphenyl)- |
1218790-87-4 |
95% |
D951811 |
Boronic acid, B-[2-(2,2,2-trifluoroethoxy)-3-pyridinyl]- |
1218790-79-4 |
95% |
Y1261279 |
Boronic acid, B-[5-fluoro-2-[(methylamino)sulfonyl]phenyl]- |
1218790-75-0 |
98% |
Y1340986 |
Benzonitrile, 4-nitro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- |
1218791-27-5 |
98% |
D746061 |
Benzenamine, N-(1,1-dimethylethyl)-2-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- |
1218791-23-1 |
95% |
Y1265540 |
1,3,2-Dioxaborolane, 2-(4-ethoxy-3-nitrophenyl)-4,4,5,5-tetramethyl- |
1218791-20-8 |
97% |
Y1339700 |
1H-Pyrrole, 1-[(4-methylphenyl)sulfonyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- |
1218791-03-7 |
98% |
Y3242268 |
Bismuth, dichlorotris[4-(trifluoromethyl)phenyl]-, (TB-5-11)- (9CI) |
121882-75-5 |
98.0% |
D754149 |
Bismuth, dichlorotris(2-methoxyphenyl)- |
121899-81-8 |
98.0% |
D745632 |
Phosphine, tris(4-methoxy-3,5-dimethylphenyl)- |
121898-64-4 |
97% |
Y3230349 |
2H-1,3,5-Thiadiazine-3(4H)-acetic acid, dihydro-5-(phenylmethyl)-6-thioxo- |
1219-77-8 |
95% |
Y1244198 |
Thalidomide-d4 |
1219177-18-0 |
98% |
Y1244089 |
2H-Pyran-4-acetic acid, a-(acetylamino)tetrahydro- |
1219171-26-2 |
97% |
Y1244046 |
Cyclopropanepropanoic acid, a-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]- |
1219163-22-0 |
98% |
Y1244104 |
Hexanoic acid, 6-(methylamino)-, hydrochloride (1:1) |
121912-30-9 |
95% |
Y1244105 |
rac Lenalidomide-13C5 |
1219332-91-8 |
99% 13C |
Y3254129 |
L-Isoleucinamide, L-threonyl-L-tyrosyl-L-alanyl-L-a-aspartyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-serylglycyl-L-arginyl-L-threonylglycyl-L-arginyl-L-arginyl-L-asparaginyl-L-alanyl- |
121932-06-7 |
97% (HPLC) |
Y3224556 |
Butanoic acid, 2,3,3-trifluoro-, ethyl ester |
1219589-17-9 |
95% |
D964698 |
5-Pyrimidinecarboxylic acid, 2-cyclopropyl-1,6-dihydro-6-oxo- |
1219561-35-9 |
95% |
D755491 |
1,3-Benzenedithiol, 5-bromo- |
1219501-75-3 |
98.0% |
D962784 |
2(3H)-Furanone, 4-ethenyldihydro-, (4R)- |
121959-61-3 |
95+% |
Y1014294 |
Lanthanum, compd. with nickel (1:5) |
12196-72-4 |
99.9% |
Y3241522 |
3-Azetidinecarboxylic acid, 1-(ethylsulfonyl)- |
1219828-33-7 |
95% |
Y1248516 |
Chlorpheniramine-D6 Maleate Salt |
1219806-45-7 |
98%D |
D951818 |
9H-Carbazole, 9-phenyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]- |
1219956-30-5 |
97% |
Y3292204 |
Ethanone, 1-(5-fluoro-1H-indol-2-yl)- |
1219930-11-6 |
95% |
Y1341047 |
2-Propenoic acid, 3-phenyl-, 3-phenylpropyl ester |
122-68-9 |
95% |
D755097 |
Ethanol, 2-(phenylamino)- |
122-98-5 |
98% |
D759875 |
1,4-Piperazinediethanol |
122-96-3 |
97% |
|
|
|
|
|
|